stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Revenue growth
Zimmer Biomet Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 6.98%, down 0.2 percentage points from fiscal 2025 (7.20%). Over the past ten years it has ranged from −23.2% (fiscal 2020) to 28.3% (fiscal 2015); the current reading is higher than 73% of that period. That is below the Medical Devices industry median of 10.4% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 7.20% | 3.35 |
| FY2024 | 3.85% | (2.70) |
| FY2023 | 6.55% | 4.90 |
| FY2022 | 1.65% | (9.77) |
| FY2021 | 11.4% | 34.66 |
| FY2020 | −23.2% | (23.86) |
| FY2019 | 0.62% | (1.04) |
| FY2018 | 1.66% | (0.10) |
| FY2017 | 1.76% | (26.09) |
| FY2016 | 27.9% | (0.49) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 3.07% | (1.73) |
| Jun 2026 | 4.80% | (4.50) |
| Mar 2026 | 9.30% | (1.60) |
| Dec 2025 | 10.9% | 1.19 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GKOS Glaukos Corporation compare | 46.9% |
| PODD Insulet Corporation compare | 26.5% |
| PEN Penumbra, Inc. compare | 17.0% |
| GMED Globus Medical, Inc. compare | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| STE STERIS plc compare | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| ZBH Zimmer Biomet Holdings, Inc. | 6.98% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement